Verition Fund Management LLC Anavex Life Sciences Corp. Transaction History
Verition Fund Management LLC
- $21.7 Billion
- Q3 2025
A detailed history of Verition Fund Management LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Verition Fund Management LLC holds 68,859 shares of AVXL stock, worth $250,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,859
Previous 32,820
109.81%
Holding current value
$250,646
Previous $302,000
102.65%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AVXL
# of Institutions
211Shares Held
32.1MCall Options Held
1.82MPut Options Held
1.09M-
Black Rock Inc. New York, NY6.39MShares$23.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$18.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.29MShares$12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.03MShares$7.38 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.04MShares$3.77 Million0.02% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $284M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...